These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8717601)

  • 1. Measuring heart patients' willingness to pay for changes in angina symptoms.
    Chestnut LG; Keller LR; Lambert WE; Rowe RD
    Med Decis Making; 1996; 16(1):65-77. PubMed ID: 8717601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay for reductions in angina pectoris attacks.
    Kartman B; Andersson F; Johannesson M
    Med Decis Making; 1996; 16(3):248-53. PubMed ID: 8818123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan.
    Chen YT; Ying YH; Chang K; Hsieh YH
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26938547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cost-of-illness with willingness-to-pay estimates to avoid shigellosis: evidence from China.
    Guh S; Xingbao C; Poulos C; Qi Z; Jianwen C; von Seidlein L; Jichao C; Wang X; Zhanchun X; Nyamete A; Clemens J; Whittington D
    Health Policy Plan; 2008 Mar; 23(2):125-36. PubMed ID: 18234703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting patient valuations of caries prevention: Using and validating the willingness to pay method.
    Vernazza CR; Wildman JR; Steele JG; Whitworth JM; Walls AW; Perry R; Matthews R; Hahn P; Donaldson C
    J Dent; 2015 Aug; 43(8):981-8. PubMed ID: 26054234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acceptance and understandability of various methods of health valuations for the chronically ill: willingness to pay, visual analogue scale and rating scale].
    Meder M; Farin E
    Gesundheitswesen; 2009 Nov; 71(11):e62-71. PubMed ID: 20094981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery.
    Haefeli M; Elfering A; McIntosh E; Gray A; Sukthankar A; Boos N
    Value Health; 2008; 11(4):575-88. PubMed ID: 18179657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The criterion validity of willingness to pay methods: A systematic review and meta-analysis of the evidence.
    Kanya L; Sanghera S; Lewin A; Fox-Rushby J
    Soc Sci Med; 2019 Jul; 232():238-261. PubMed ID: 31108330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonparametric willingness-to-pay measures and confidence statements.
    Tambour M; Zethraeus N
    Med Decis Making; 1998; 18(3):330-6. PubMed ID: 9679998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Valuation of Selected Illnesses in Environmental Public Health Tracking.
    Zhou Y; Nurmagambetov T; McCord M; Hsu WH
    J Public Health Manag Pract; 2017; 23 Suppl 5 Supplement, Environmental Public Health Tracking():S18-S27. PubMed ID: 28763382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems.
    Flowers CR; Garber AM; Bergen MR; Lenert LA
    Proc AMIA Annu Fall Symp; 1997; ():223-7. PubMed ID: 9357621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of contingent valuation for health economics.
    Bayoumi AM
    Pharmacoeconomics; 2004; 22(11):691-700. PubMed ID: 15250748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to pay for a QALY.
    Gyrd-Hansen D
    Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for lung cancer treatment.
    Lang HC
    Value Health; 2010; 13(6):743-9. PubMed ID: 20561327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylnaltrexone in the treatment of opioid-induced constipation in cancer patients receiving palliative care: willingness-to-pay and cost-benefit analysis.
    Iskedjian M; Iyer S; Librach SL; Wang M; Farah B; Berbari J
    J Pain Symptom Manage; 2011 Jan; 41(1):104-15. PubMed ID: 20832981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for health care services in common cold, retinal detachment, and myocardiac infarction: an internet survey in Japan.
    Yasunaga H; Ide H; Imamura T; Ohe K
    BMC Health Serv Res; 2006 Feb; 6():12. PubMed ID: 16504017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
    Pinto-Prades JL; Farreras V; de Bobadilla JF
    Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingent valuation scenarios for chronic illnesses: the case of childhood asthma.
    Brandt S; Vásquez Lavín F; Hanemann M
    Value Health; 2012 Dec; 15(8):1077-83. PubMed ID: 23244810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.